Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gene test may take guesswork out of cancer pain relief

NCT ID NCT06511401

Recruiting now Knowledge-focused Sponsor: University of Chicago Source: ClinicalTrials.gov ↗

First seen May 09, 2026 · Last updated May 09, 2026

Summary

This study looks at whether checking a person's genes before prescribing pain medicine can lead to better pain control for cancer patients. Researchers will give some participants a genetic test and use the results to guide opioid choice, while others receive standard care. The goal is to see if the genetic approach reduces pain scores and leads to fewer medication changes. The study plans to enroll 800 adults receiving cancer care at the University of Chicago.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULT PATIENTS WHO ARE RECEIVING ONCOLOGIC CARE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Chicago Medicine Comprehensive Cancer Center

    RECRUITING

    Chicago, Illinois, 60637, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.

ADULT PATIENTS WHO ARE RECEIVING ONCOLOGIC CARE